Graduate Institute of Biostatistics, School of Public Health, China Medical University, Taichung, Taiwan.
Genetic Center, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
J Gene Med. 2021 Feb;23(2):e3305. doi: 10.1002/jgm.3305. Epub 2021 Jan 22.
Patients with type 2 diabetes mellitus (T2DM) experience a two-fold increased risk of cardiovascular diseases. Genome-wide association studies (GWAS) have identified T2DM susceptibility genetic variants. Interestingly, the genetic variants associated with cardiovascular disease risk in T2DM Han Chinese remain to be elucidated. The present study aimed to investigate the genetic variants associated with cardiovascular disease risk in T2DM.
We performed bootstrapping, GWAS and an investigation of genetic variants associated with cardiovascular disease risk in a discovery T2DM cohort and in a replication cohort. The discovery cohort included 326 cardiovascular disease patients and 1209 noncardiovascular disease patients. The replication cohort included 68 cardiovascular disease patients and 317 noncardiovascular disease patients. The main outcome measures were genetic variants for genetic risk score (GRS) in cardiovascular disease risk in T2DM.
In total, 35 genetic variants were associated with cardiovascular disease risk. A GRS was generated by combining risk alleles from these variants weighted by their estimated effect sizes (log odds ratio [OR]). T2DM patients with weighted GRS ≥ 12.63 had an approximately 15-fold increase in cardiovascular disease risk (odds ratio = 15.67, 95% confidence interval [CI] = 10.33-24.00) compared to patients with weighted GRS < 10.39. With the addition of weighted GRS, receiver-operating characteristic curves showed that area under the curve with conventional risk factors was improved from 0.719 (95% CI = 0.689-0.750) to 0.888 (95% CI = 0.866-0.910).
These 35 genetic variants are associated with cardiovascular disease risk in T2DM, alone and cumulatively. T2DM patients with higher levels of weighted genetic risk score have higher cardiovascular disease risks.
2 型糖尿病(T2DM)患者患心血管疾病的风险增加一倍。全基因组关联研究(GWAS)已确定 T2DM 易感遗传变异。有趣的是,T2DM 汉族人群与心血管疾病风险相关的遗传变异仍有待阐明。本研究旨在探讨 T2DM 患者与心血管疾病风险相关的遗传变异。
我们在一个发现 T2DM 队列和一个复制队列中进行了自举、GWAS 以及与心血管疾病风险相关的遗传变异的研究。发现队列包括 326 例心血管疾病患者和 1209 例非心血管疾病患者。复制队列包括 68 例心血管疾病患者和 317 例非心血管疾病患者。主要观察指标为 T2DM 患者心血管疾病风险的遗传风险评分(GRS)的遗传变异。
共有 35 个遗传变异与心血管疾病风险相关。通过将这些变异的风险等位基因按其估计效应大小(对数优势比[OR])加权,生成 GRS。加权 GRS≥12.63 的 T2DM 患者发生心血管疾病的风险约增加 15 倍(比值比=15.67,95%置信区间[CI]为 10.33-24.00),而加权 GRS<10.39 的患者则较低。在加入加权 GRS 后,接受者操作特征曲线显示,常规危险因素的曲线下面积从 0.719(95%CI=0.689-0.750)提高到 0.888(95%CI=0.866-0.910)。
这些 35 个遗传变异单独和累积与 T2DM 患者的心血管疾病风险相关。具有较高加权遗传风险评分的 T2DM 患者具有更高的心血管疾病风险。